USANA Health Sciences (USNA) Peer Comparison
$13.63
$-0.23
(-1.66%)
As on 06-Nov-2026 16:00EST
Market cap
$256 Mln
Revenue (TTM)
$906 Mln
P/E Ratio
--
P/B Ratio
0.5
Div. Yield
0 %
Edit
| USANA Health Sciences (USNA) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | Seaboard (SEB) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
256 | 8,001 | 6,793 | 5,560 | 3,379 |
Revenue ($ Mln) |
906 | 6,785 | 18,330 | 1,109 | 10,503 |
Net Profit ($ Mln) |
-21.20 | 845.55 | 320.40 | 170.85 | 552.00 |
Net Margin (%) |
-2.34 | 12.46 | 1.75 | 15.41 | 5.26 |
RoE (%) |
-2.77 | 34.41 | 8.47 | 13.08 | 10.10 |
Price to Earnings |
-- | 9.64 | 21.29 | 32.91 | 6.15 |
Price-To-Book |
0.50 | 1.67 | 1.76 | 4.32 | 0.59 |
Income Statement ($ Mln)
| USANA Health Sciences (USNA) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | Seaboard (SEB) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
905.58 | 6,784.87 | 18,329.91 | 1,108.98 | 10,503.00 |
|
Cost of Revenue
|
205.90 | 5,062.58 | 16,882.40 | 704.60 | 9,748.00 |
|
Gross Profit
|
724.41 | 969.46 | 2,358.14 | 370.63 | 677.00 |
|
Operating Expenses
|
690.00 | 620.76 | 820.62 | 167.03 | 487.00 |
|
Operating Profit (EBIT)
|
9.68 | 1,101.53 | 626.88 | 237.35 | 268.00 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
-0.06 | 1,068.57 | 488.64 | 220.38 | 519.00 |
|
Provision for Tax
|
29.42 | 215.05 | 169.72 | 49.53 | -39.00 |
|
Profit after Tax (Net Income)
|
-21.20 | 845.55 | 320.40 | 170.85 | 552.00 |
|
Minority Interest
|
6.39 | -6.64 | 1.48 | 0.00 | -4.00 |
|
Consolidated Profit
|
0.00 | 56.94 | 0.00 | 0.00 | 253.00 |
Liabilities ($ Mln)
| USANA Health Sciences (USNA) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | Seaboard (SEB) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
526.76 | 0.00 | 3,875.62 | 1,326.78 | 5,513.00 |
|
Minority Interest
|
6.39 | -6.64 | 1.48 | 0.00 | -4.00 |
|
Non-Current Liabilities
|
26.12 | 0.00 | 4,159.33 | 212.68 | 1,462.00 |
|
Current Liabilities
|
112.25 | 0.00 | 2,889.21 | 164.12 | 1,785.00 |
|
Total Liabilities
|
742.92 | 10,298.78 | 10,343.53 | 1,707.56 | 8,246.00 |
Assets ($ Mln)
| USANA Health Sciences (USNA) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | Seaboard (SEB) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
418.23 | 2,831.70 | 6,470.08 | 1,298.70 | 4,578.00 |
|
Current Assets
|
290.24 | 121.72 | 4,466.34 | 404.88 | 4,204.00 |
|
Total Assets
|
742.92 | 10,298.78 | 10,343.53 | 1,707.56 | 8,246.00 |
|
Total Debt*
|
0.00 | 0.00 | 3,661.89 | 142.44 | 2,060.00 |
|
Net Current Assets
|
0.00 | 0.00 | 1,577.13 | 240.76 | 0.00 |
Cashflow ($ Mln)
| USANA Health Sciences (USNA) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | Seaboard (SEB) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
22.35 | 1,059.72 | 1,371.65 | 216.56 | 568.00 |
|
Cash Flow from Investing Activities
|
-10.13 | -720.28 | -705.51 | -43.89 | -543.00 |
|
Cash from Financing Activities
|
-40.60 | -337.89 | -2,113.00 | -152.81 | 44.00 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| USANA Health Sciences (USNA) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | Seaboard (SEB) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
1.92 | 0.72 | 14.69 | 11.03 | 7.31 |
|
ROE (%)
|
-2.77 | 34.41 | 8.47 | 13.08 | 10.10 |
|
ROA (%)
|
-2.30 | 11.63 | 2.42 | 9.35 | 4.93 |
|
EBIT Margin (%)
|
0.04 | 15.63 | 3.53 | 20.40 | 3.23 |
|
Net Margin (%)
|
-2.34 | 12.46 | 1.75 | 15.41 | 5.26 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| USANA Health Sciences (USNA) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | Seaboard (SEB) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-0.78 | 16.25 | -0.12 | 9.42 | 6.98 |
|
EBIT Growth (%)
|
-99.30 | 237.66 | -63.51 | 10.70 | -22.43 |
|
Net Profit Growth (%)
|
-224.55 | 684.57 | -73.96 | 14.51 | 38.69 |
|
EPS Growth (%)
|
-228.50 | 687.47 | -74.00 | 16.26 | 39.63 |
|
Book Value Growth (%)
|
-1.35 | -- | 9.19 | 4.37 | 11.47 |
Valuation Ratios
| USANA Health Sciences (USNA) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | Seaboard (SEB) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
33.39 | 91.95 | 8.59 | 32.01 | 8.64 |
|
Price / Book Value
|
0.67 | 1.22 | 2.53 | 3.94 | 0.82 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
2.62 | 12.42 | 5.67 | 19.90 | 8.04 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| USANA Health Sciences (USNA) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | Seaboard (SEB) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.88 | 0.88 | 0.09 | 0.00 |
|
Short term debt to equity ratio
|
0.00 | 0.03 | 0.00 | 0.00 | 0.16 |
|
Current Ratio
|
2.59 | 1.50 | 1.55 | 2.47 | 2.36 |
|
Quick Ratio
|
1.84 | 0.99 | 0.83 | 1.39 | 1.37 |
|
Interest Coverage
|
0.85 | 4.29 | 4.08 | 26.46 | 8.21 |
Operating Efficiency Ratios
| USANA Health Sciences (USNA) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | Seaboard (SEB) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
0.56 | 0.00 | 5.52 | 13.13 | 7.66 |
|
Asset Turnover
|
0.98 | 0.93 | 1.39 | 0.61 | 0.94 |
|
Receivable days
|
3.25 | 37.99 | 23.31 | 46.35 | 28.99 |
|
Inventory Days
|
156.70 | 39.01 | 43.17 | 71.86 | 58.82 |
|
Payable days
|
26.59 | 25.42 | 30.21 | 31.56 | 16.41 |
|
Cash Conversion Cycle
|
133.36 | 51.58 | 36.27 | 86.65 | 71.40 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
